DLGAP1-AS3

Across TCGA pan-cancer cohorts, DLGAP1-AS3 RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of DLGAP1-AS3’s most consistent transcriptional readouts.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where DLGAP1-AS3 RNA is repressed in tumor relative to normal tissue. In most cancer types DLGAP1-AS3 is over-expressed in tumor, although a few such as UCEC and LUSC show the opposite, repressed pattern.

UCEC, LUSC, and KICH are the cancer types where DLGAP1-AS3 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in DLGAP1-AS3 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
UCEC	All	II,III,IV	−0.303	.023	4	view →
LUSC	All	All	−0.066	.002	4	view →
KICH	Male	II,III,IV	−0.156	.035	3	view →
PRAD	All	All	−0.402	.007	2	view →
PAAD	Male	All	−0.205	.044	2	view →
KIRC	Female	III,IV	−0.195	.022	2	view →
THCA	All	All	+0.029	<.001	2	view →
COAD	Female	II,III,IV	−0.012	.034	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

DLGAP1-AS3–UCEC

Open the UCEC breakdown →